Internalization of CD40 regulates its signal transduction in vascular endothelial cells

Area of Science:

• Immunology
• Vascular Biology
• Cellular Signaling

Background:

• The CD40 ligand (CD40L)-CD40 interaction promotes atherosclerosis by activating vascular endothelium.
• Both membrane-bound (mCD40L) and soluble (sCD40L) forms of CD40L exist, but their distinct roles in endothelial inflammation are unclear.

Purpose of the Study:

• To investigate the differential effects of mCD40L and sCD40L on endothelial cells and CD40 signaling pathways.
• To elucidate the molecular mechanisms underlying CD40L-mediated endothelial activation in atherosclerosis.

Main Methods:

• Utilized an agonistic CD40 antibody (G28.5) mimicking sCD40L and cell-surface expressed CD40L.
• Employed techniques including endocytosis assays, Rab5 mutant expression, NF-kappaB activation studies, and analysis of TRAF2/3/6 recruitment and Akt phosphorylation.
• Assessed the impact on proinflammatory cytokine and cell adhesion factor expression in primary human vascular endothelial cells.

Main Results:

• sCD40L (mimicked by G28.5) induced rapid CD40 endocytosis independent of TRAF2/3/6, activating NF-kappaB signaling within early endosomes.
• mCD40L captured CD40 at cell junctions, leading to distinct intracellular signaling patterns compared to internalized CD40.
• Only mCD40L upregulated proinflammatory cytokines and cell adhesion factors in endothelial cells, despite both forms activating NF-kappaB.

Conclusions:

• Membrane-bound CD40L, not soluble CD40L, is the primary trigger for endothelial proinflammatory responses relevant to atherosclerosis.
• Differential CD40 trafficking and signaling complex formation dictate the outcome of CD40L-endothelial cell interactions.
• Understanding these distinct pathways is crucial for targeting CD40L-mediated mechanisms in atherosclerosis treatment.